Our BoardCommNexus is a non-profit organization that is member supported. We rely on the sponsorship of industry companies, along with the participation of individuals from our community, to assist us in helping the San Diego technology community. Our Board of Directors is comprised of representatives from our sponsor companies and industry advisors.
At the heart of EvoNexus is a driven team working tirelessly to ensure EvoNexus provides startups with the support and opportunities needed to prosper and pioneer the future of technology.
Partner, DLA Piper
Larry Nishnick advises both private emerging growth companies and established, public company clients throughout a broad range of industries, including technology, software, life sciences and healthcare, sports, media, entertainment, consumer products and retail, consumer finance, cleantech and the internet of things. Larry also advises private equity, venture capitalists and angel investors in connection with their investments. Larry advises clients from the initial formation and early-stage fundraisings through later-stage venture capital and private equity financings to IPOs and follow-on offerings, PIPEs and debt financings. Larry has extensive experience in mergers and acquisitions, joint ventures, partnerships, collaborations and other strategic transactions.
Larry’s practice also includes SEC disclosure and reporting requirements, including 1933 Act and 1934 Act disclosure and the reporting requirements of NYSE, NASDAQ and AMEX. Larry’s experience is extensive with deals ranging from angel investments to multi-billion dollar acquisitions. His recent representation of companies includes QUALCOMM, World Wresting Entertainment (WWE), Live Nation Worldwide, The Coca-Cola Company, ViaSat, Lufthansa, Provide Commerce, Jack-in-the-Box, Cross-Fit, Barclays Bank and a vast number of private emerging growth technology companies.
Larry’s recent representation of companies in the life sciences and healthcare sectors includes NuVasive Life Technologies, BioFire Diagnostics, bioMérieux, Neothetics, Cypher Genomics, Cytori Therapeutics, Mast Therapeutics, Halozyme Therapeutics, Epic Sciences, BiologicTx and a number of emerging growth companies in the therapeutics, diagnostics, aesthetics, genomics and healthcare industries.
Before joining DLA Piper, Larry served as executive vice president, general counsel and secretary to telecommunications company and as a general counsel at a speciality pharmaceuticals company. Based on these in-house executive positions, he gained valuable experience on day-to-day legal and business matters while managing worldwide legal operations and was responsible for worldwide business development, corporate services and operations.